Differential effects of selective HDAC inhibitors on macrophage inflammatory responses to the Toll-like receptor 4 agonist LPS
The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
Selective inhibitor studies in macrophages implicate class II HDAC enzymes in TLR-mediated inflammatory pathways and class I HDACs as negative regulators. Broad-spectrum inhibitors of HDACs are therapeutic in many inflammatory disease models but exacerbated disease in a mouse model of atherosclerosis. HDAC inhibitors have anti- and proinflammatory effects on macrophages in vitro. We report here that several broad-spectrum HDAC inhibitors, including TSA and SAHA, suppressed the LPS-induced mRNA expression of the proinflammatory mediators Edn-1, Ccl-7/MCP-3, and Il-12p40 but amplified the expression of the proatherogenic factors Cox-2 and Pai-1/serpine1 in primary mouse BMM. Similar effects were also apparent in LPS-stimulated TEPM and HMDM. The pro- and anti-inflammatory effects of TSA were separable over a concentration range, implying that individual HDACs have differential effects on macrophage inflammatory responses. The HDAC1-selective inhibitor, MS-275, retained proinflammatory effects (amplification of LPS-induced expression of Cox-2 and Pai-1 in BMM) but suppressed only some inflammatory responses. In contrast, 17a (a reportedly HDAC6-selective inhibitor) retained anti-inflammatory but not proinflammatory properties. Despite this, HDAC6−/− macrophages showed normal LPS-induced expression of HDAC-dependent inflammatory genes, arguing that the anti-inflammatory effects of 17a are not a result of inhibition of HDAC6 alone. Thus, 17a provides a tool to identify individual HDACs with proinflammatory properties.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As drug inhibition of cellular deacetylases strongly attenuates pathogen-and immunogen-induced immune responses (139–141), it is tempting to speculate that acetylation plays a key role in modulating immune signaling pathways.”
From The Impact of Mass Spectrometry–Based Proteomics on Fundamental Discoveries in Virology (2014) · cites this paper as [139]
Citations
Cites
Histone deacetylases (HDACs): characterization of the classical HDAC family
RUIJTER, A. J. M. D., GENNIP, A. H. V., CARON, H. N., KEMP, S., & KUILENBURG, A. B. P. V. (2003) · Biochemical Journal · doi:10.1042/bj20021321 · Cited by 3,114
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
Minucci, S., & Pelicci, P. G. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1779 · Cited by 2,200
Butyrate inhibits inflammatory responses through NFκB inhibition: implications for Crohn's disease
Segain, J.-P., de la Blétière, D. R., Bourreille, A., Leray, V, Gervois, N., Rosales, C., Ferrier, L., Bonnet, C., Blottière, H. M., & Galmiche, J.-P. (2000) · Gut · doi:10.1136/gut.47.3.397 · Cited by 1,321
Marks, P. A., & Breslow, R. (2007) · Nature Biotechnology · doi:10.1038/nbt1272 · Cited by 1,196
Haggarty, S. J., Koeller, K. M., Wong, J. C., Grozinger, C. M., & Schreiber, S. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0430973100 · Cited by 1,066
Histone Deacetylase Inhibitors in Cancer Therapy
Lane, A. A., & Chabner, B. A. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.1291 · Cited by 874
Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression
Lagger, G., O'Carroll, D., Rembold, M., Khier, H., Tischler, J., Weitzer, G., Schuettengruber, B., Hauser, C., Brunmeir, R., Jenuwein, T., et al. (2002) · The EMBO Journal · doi:10.1093/emboj/21.11.2672 · Cited by 760 · cited 2×
“To assess the selectivity of MS-275, compound 17a, and compound 7 in macrophages, we first examined the hyperacetylation of HDAC substrates, HDAC1 and HDAC6 deacetylate histone H3, [35] and -tubulin [39], respectively.”
BackgroundIto, K., Yamamura, S., Essilfie-Quaye, S., Cosio, B., Ito, M., Barnes, P. J., & Adcock, I. M. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20050466 · Cited by 638
Histone acetylation and deacetylation: importance in inflammatory lung diseases
Barnes, P. J., Adcock, I. M., & Ito, K. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00117504 · Cited by 564
Mice Lacking Histone Deacetylase 6 Have Hyperacetylated Tubulin but Are Viable and Develop Normally
Zhang, Y., Kwon, S., Yamaguchi, T., Cubizolles, F., Rousseaux, S., Kneissel, M., Cao, C., Li, N., Cheng, H.-L., Chua, K., et al. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01154-06 · Cited by 559 · cited 1×
“To assess the selectivity of MS-275, compound 17a, and compound 7 in macrophages, we first examined the hyperacetylation of HDAC substrates, HDAC1 and HDAC6 deacetylate histone H3, [35] and -tubulin [39], respectively.”
BackgroundSelf-citation
Cited by
Items 101–200 of 201
Zhang, S., Zhan, L., Li, X., Yang, Z., Luo, Y., & Zhao, H. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.62001 · Cited by 32
Pradhan, P., Upadhyay, N., Tiwari, A., & Singh, L. P. (2016) · New Frontiers in Ophthalmology · doi:10.15761/nfo.1000145 · Cited by 32
Histone deacetylase 9 deficiency exaggerates uterine M2 macrophage polarization
Liu, Y., Du, M., & Lin, H. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16616 · Cited by 31
The role of acetylation in TLR4‐mediated innate immune responses
Hu, X., Yu, Y., Chin, Y. E., & Xia, Q. (2013) · Immunology and Cell Biology · doi:10.1038/icb.2013.56 · Cited by 31
Tng, J., Lim, J., Wu, K., Lucke, A. J., Xu, W., Reid, R. C., & Fairlie, D. P. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00230 · Cited by 31
Self-citationEpigenetic Alterations Induced by Bacterial Lipopolysaccharides
Chiariotti, L., Coretti, L., Pero, R., & Lembo, F. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-24738-0_5 · Cited by 30
Epigenetics in Vascular Disease – Therapeutic Potential of New Agents
Xu, S., Alam, S., & Margariti, A. (2014) · Current Vascular Pharmacology · doi:10.2174/157016111201140327155551 · Cited by 28
Epigenetics and innate immunity: the ‘unTolld’ story
Hennessy, C., & McKernan, D. P. (2016) · Immunology and Cell Biology · doi:10.1038/icb.2016.24 · Cited by 28
Targeting Transcription Factor Lysine Acetylation in Inflammatory Airway Diseases
van den Bosch, T., Kwiatkowski, M., Bischoff, R., & Dekker, F. J. (2017) · Epigenomics · doi:10.2217/epi-2017-0027 · Cited by 28
Sanchez, S., Lemmens, S., Baeten, P., Sommer, D., Dooley, D., Hendrix, S., & Gou-Fàbregas, M. (2018) · Experimental Neurobiology · doi:10.5607/en.2018.27.5.437 · Cited by 28
Effect of Histone Deacetylase Inhibitor JNJ-26481585 in Pain
Capasso, K. E., Manners, M. T., Quershi, R. A., Tian, Y., Gao, R. Y., Hu, H., Barrett, J. E., Saçan, A., & Ajit, S. K. (2014) · Journal of Molecular Neuroscience · doi:10.1007/s12031-014-0391-7 · Cited by 28
Epigenetic Modifiers: Anti-Neoplastic Drugs With Immunomodulating Potential
Maes, K., Mondino, A., Lasarte, J. J., Agirre, X., Vanderkerken, K., Prósper, F., & Breckpot, K. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.652160 · Cited by 26
LBH589 Enhances T Cell Activation In Vivo and Accelerates Graft-versus-Host Disease in Mice
Wang, D., Iclozan, C., Liu, C., Xia, C., Anasetti, C., & Yu, X. (2012) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2012.06.002 · Cited by 26
Metabolic Modulation of Macrophage Function Post Myocardial Infarction
Zhao, M., Wang, D. D.-H., Liu, X., & Tian, R. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00674 · Cited by 25
Kovács‐Kása, A., Kovács, L., Cherian‐Shaw, M., Patel, V. S., Meadows, M. L., Fulton, D. J., Su, Y., & Verin, A. D. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.30053 · Cited by 25
Up‐regulation of HDACs, a harbinger of uraemic endothelial dysfunction, is prevented by defibrotide
Palomo, M., Vera, M., Martin, S., Torramadé‐Moix, S., Martínez-Sánchez, J., Moreno, A. B., Carreras, E., Escolar, G., Cases, A., & Díaz‐Ricart, M. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14865 · Cited by 24
Importance of Metabolic Memory in the Development of Vascular Complications in Diabetic Patients
Luna, P., Guarner‐Lans, V., Farías, J. M., Hernández‐Pacheco, G., & Martínez, M. (2016) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2016.02.008 · Cited by 26
Munro, S. K., Mitchell, M. D., & Ponnampalam, A. P. (2013) · Placenta · doi:10.1016/j.placenta.2013.04.004 · Cited by 22
HDAC inhibitors block innate immunity
Bode, K. A., & Dalpke, A. H. (2011) · Blood · doi:10.1182/blood-2010-11-315820 · Cited by 22
Manipulation of the host protein acetylation network by human immunodeficiency virus type 1.
Jeng, M. Y., Ali, I., & Ott, M. (2015) · PubMed · doi:10.3109/10409238.2015.1061973 · Cited by 22
Shen, J., Wu, S., Guo, W., Liang, S., Li, X., & Yang, X. (2016) · Immunobiology · doi:10.1016/j.imbio.2016.09.009 · Cited by 21
Ramnath, D., Gupta, K. D., Wang, Y., Abrol, R., Curson, J. E. B., Lim, J., Reid, R. C., Mansell, A., Blumenthal, A., Karunakaran, D., et al. (2021) · Journal of Leukocyte Biology · doi:10.1002/jlb.2mr1021-260r · Cited by 20
Self-citationSugiura, S., Ishihara, Y., Komatsu, T., Hagiwara, M., Tanigawa, N., Kato, Y., Mizutani, H., Kawahara, K., Maruyama, I., Noguchi, T., et al. (2011) · Shock · doi:10.1097/shk.0b013e31822f7e58 · Cited by 20
Role of Histone Deacetylase Inhibitor in Diabetic Painful Neuropathy
Thakur, V., Gonzalez, M. A., Parada, M., Martinez, R. D., & Chattopadhyay, M. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03701-4 · Cited by 19
Dose-dependent dual effects of HDAC inhibitors on glial inflammatory response
Mancino, S., Boraso, M., Galmozzi, A., Serafini, M. M., Fabiani, E. D., Crestani, M., & Viviani, B. (2025) · Scientific Reports · doi:10.1038/s41598-025-96241-x · Cited by 19
Chen, W.-L., Sheu, J., Hsiao, C., Hsiao, S.-H., Chung, C., & Hsiao, G. (2014) · BioMed Research International · doi:10.1155/2014/231012 · Cited by 19
Halai, R., Croker, D. E., Suen, J. Y., Fairlie, D. P., & Cooper, M. A. (2012) · Biosensors · doi:10.3390/bios2030273 · Cited by 18
Self-citationRodríguez-López, G. M., Soria-Castro, R., Campillo-Navarro, M., Pérez‐Tapia, S. M., Flores‐Borja, F., Wong‐Baeza, I., Muñoz-Cruz, S., López‐Santiago, R., Estrada-Parra, S. A., Estrada‐García, I., et al. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.3ab0320-547rr · Cited by 18
Biocompatible valproic acid-coupled nanoparticles attenuate lipopolysaccharide-induced inflammation
Kühne, M., Kretzer, C., Lindemann, H., Godmann, M., Heinze, T. J., Werz, O., & Heinzel, T. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120567 · Cited by 18
Biswas, B., & Yenugu, S. (2012) · Immunogenetics · doi:10.1007/s00251-012-0674-5 · Cited by 17
Cho, D.-Y., Han, J., Kim, I. S., Lim, J.-H., Ko, H. M., Kim, B.-W., & Choi, D. (2025) · Science Signaling · doi:10.1126/scisignal.adp8973 · Cited by 16
Personalized Epigenetic Management of Diabetes
Fodor, A., Cozma, A., & Karnieli, E. (2015) · Personalized Medicine · doi:10.2217/pme.15.17 · Cited by 16
Macrophages: friend or foe in diabetes pathogenesis and therapy
Grimes, R. N., Orecchioni, M., & Quesada‐Masachs, E. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1625391 · Cited by 15
Rationale for HDAC Inhibitor Therapy in Autoimmunity and Transplantation
Hancock, W. W. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-21631-2_6 · Cited by 16
Hu, C., Meng, X., Huang, C., Shen, C., & Li, J. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.2hi1115-491r · Cited by 15
Schioppa, T., Nguyen, H. O., Tiberio, L., Sozio, F., Gaudenzi, C., Passari, M., Prete, A. D., Bosisio, D., & Salvi, V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179752 · Cited by 14
Class IIa HDACs inhibitor TMP269 promotes M1 polarization of macrophages after spinal cord injury
Qi, X., & Wang, P. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26446 · Cited by 13
Role of HDAC6 inhibition in sepsis‑induced acute respiratory distress syndrome (Review)
Zhang, Q., Wang, Y., Qu, D., Yu, J., & Yang, J. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.9866 · Cited by 13
Hendrix, S., Sanchez, S., Ventriglia, E., & Lemmens, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124539 · Cited by 13
Zhao, G., Jia, J., Wang, L., Zhang, Y., Yang, H., Lü, Y., Yu, R., Liu, H., & Zhu, Y. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s273527 · Cited by 12
Özkan, A. D., Eskiler, G. G., Turna, O., & Kazan, N. (2022) · Journal of Cancer Research and Therapeutics · doi:10.4103/jcrt.jcrt_2032_21 · Cited by 12
del Campo, C. M. Z.-M., Rosas, M., & Guarner‐Lans, V. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051456 · Cited by 12
Li, Z., Li, A., Liu, P., Zhang, B., & Yan, Y. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1485642 · Cited by 11
Pyroglutamylated RF-amide Peptide (QRFP) Gene Is Regulated by Metabolic Endotoxemia
Jossart, C., Mulumba, M., Granata, R., Gallo, D., Ghigo, E., Marleau, S., Servant, M. J., & Ong, H. (2013) · Molecular Endocrinology · doi:10.1210/me.2013-1027 · Cited by 11
Epigenetic modulation of immunotherapy cofactors to enhance tumor response in lung cancer
Kommalapati, A., & Tanvetyanon, T. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1764273 · Cited by 10
Truong, N., Cottingham, A. L., Dharmaraj, S., Shaw, J. R., Lasola, J. J., Goodis, C. C., Fletcher, S., & Pearson, R. M. (2023) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10611 · Cited by 9
Ourailidou, M. E., Leus, N. G. J., Krist, K., Lenoci, A., Mai, A., & Dekker, F. J. (2016) · MedChemComm · doi:10.1039/c6md00375c · Cited by 10
Monocyte Subsets and Their Role in Tumor Progression
Doseff, A. I., & Parihar, A. (2012) · InTech eBooks · doi:10.5772/32615 · Cited by 8
Dobreva, Z. G., Grigorov, B., & Stanilova, S. A. (2016) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2016.1188940 · Cited by 8
Zhang, Y., Zhao, Y., Wang, Y., Li, J., Huang, Y., Lyu, F., Wang, Y., Wei, P., Yuan, Y., Fu, Y., et al. (2023) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x231197173 · Cited by 7
IL-4 and HDAC Inhibitors Suppress Cyclooxygenase-2 Expression in Human Follicular Dendritic Cells
Cho, W., Hong, S. H., & Choe, J. (2013) · Immune Network · doi:10.4110/in.2013.13.2.75 · Cited by 7
HDAC6 Deficiency Has Moderate Effects on Behaviors and Parkinson’s Disease Pathology in Mice
Zhao, J., He, Y., Duan, Y., Ma, Y., Dong, H., Zhang, X., Fang, R., Zhang, Y., Yu, M., & Huang, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24129975 · Cited by 6
Li, X., Zhang, Q., Ding, Y., Liu, Y., Zhao, D., Zhao, K., Shen, Q., Liu, X., Zhu, X., Li, N., et al. (2016) · Nature Immunology · doi:10.1038/ni0816-1005d · Cited by 6
van den Bosch, T., Leus, N. G. J., Timmerman, T., & Dekker, F. J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802208-5.00008-4 · Cited by 4
Effect of a Histone Deacetylases Inhibitor of IL-18 and TNF-Alpha Secretion in Vitro
Dobreva, Z. G., Grigorov, B., & Stanilova, S. A. (2018) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2018.075 · Cited by 4
DAMP-Promoted Efferent Innate Immune Responses in Human Diseases: Inflammation
Land, W. G. (2020) · Springer eBooks · doi:10.1007/978-3-030-53868-2_5 · Cited by 4
HDAC6-Mediated FoxO1 Acetylation And Phosphorylation Control Periodontal Inflammatory ResponsesPreprint
Lohner, H., Han, X., Ren, J., Liang, S., Liang, R., & Wang, H. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.12.10.627820 · Cited by 4
Histone Deactylase Inhibitors as Novel Target for Cancer, Diabetes, and Inflammation
Singh, P., & Madhavan, T. (2013) · Journal of the Chosun Natural Science · doi:10.13160/ricns.2013.6.1.057 · Cited by 3
Nakayasu, E. S., Brown, R. N., Ansong, C. K., Sydor, M. A., Imtiaz, S., Mihai, C., Sontag, R. L., Hixson, K. K., Monroe, M. E., Sobreira, T. J. P., et al. (2013) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m112.026138 · Cited by 3
Epigenetics of Diabetes in Humans
Nano, J., Portilla-Fernández, E., Troup, J., Ghanbari, M., Franco, O. H., & Muka, T. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812215-0.00016-9 · Cited by 3
Hara, H., Aki, M., & Kamiya, T. (2024) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b24-00111 · Cited by 3
Epigenetic programming of macrophages across inflammatory and malignant diseases
Mohammad, S. I., Owida, H. A., Vasudevan, A., Ballal, S., Alshdaifat, N., Akberzeda, A., Singh, A., Kavitha, V., Maharana, L., & Sharma, M. K. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04758-9 · Cited by 2
Therapeutic properties of plant-derived prebiotics in melanoma
Kay, E. J., Kazi, M., Burton, J. P., & Parvathy, S. N. (2025) · Exploration of Targeted Anti-tumor Therapy · doi:10.37349/etat.2025.1002354 · Cited by 2
Therapeutic Potential of HDAC Inhibitors in Neurodegenerative Diseases
Singh, A. K., Sudhan, Y. G., Chandana, S. L., Iyaswamy, A., & Durairajan, S. S. K. (2026) · Springer eBooks · doi:10.1007/978-981-95-6099-8_14 · Cited by 2
Diabetic wound healing with engineered biomaterials
Castellano, L. E., Delgado, J., Vega‐González, A., & Mendoza‐Novelo, B. (2020) · Elsevier eBooks · doi:10.1016/b978-0-08-102906-0.00005-2 · Cited by 2
Comalada, M., Serrat, N., & Xaus, J. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0710401 · Cited by 2
The Role of Histone Deacetylases in Cytokine Regulation in Human Gestational Tissues
Munro, S. K. (2013) · ResearchSpace (University of Auckland) · Cited by 2
Investigating the epigenetic regulation of toll-like receptor 3
Hennessy, C. (2017) · Arrow@dit (Dublin Institute of Technology) · doi:10.13025/17930 · Cited by 2
Yıldırım-Buharalıoğlu, G., Sala‐Newby, G. B., Bond, M., & Newby, A. C. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-10872-x · Cited by 1
Regulation of the Jak/STATs Pathways by Histone Deacetylases
Woods, D. M., Lienlaf, M., Sotomayor, E. M., Seto, E., & Villagra, A. (2013) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-1-4614-8039-6_7 · Cited by 1
Sun, Z., Yang, T., Wang, Y., Li, C., Yang, Y., Wang, D., Guo, J., Shi, T., Wang, Y., Qu, Y., et al. (2020) · Pharmacognosy Magazine · doi:10.4103/pm.pm_306_19 · Cited by 1
Абдурасуловна, Ш. У., Tashkent, U., & Bekjanova, O. (2016) · International Journal of Biomedicine · doi:10.21103/article6(1)_oa16 · Cited by 1
Microglial alterations in valproic acid models of autism
Awale, P. S. (2012) · OhioLink ETD Center (Ohio Library and Information Network) · Cited by 1
Chen, W., Chen, M.-C., Hsu, S.-F., Hsiao, S.-H., & Chung, C. (2021) · Pharmaceuticals · doi:10.3390/ph14060585 · Cited by 1
Beneficial and detrimental effects of cytokines after spinal cord injury
Amo‐Aparicio, J., & Penas, C. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-822427-4.00009-5 · Cited by 1
Descalzi‐Montoya, D. B., Dai, J., Singh, S., & Fitzgerald-Bocarsly, P. A. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.09.085456 · Cited by 1
Fischer, N. (2014) · theses.fr (ABES) · doi:10.70675/7ecf88e2z7851z4354zb134z317e666a94cb · Cited by 1
Jossart, C. (2012) · doi:10.71781/4629 · Cited by 1
Woodward, E. (2011) · Murdoch University Research Portal
Novel mechanisms regulating inflammatory gene expression in adipocytes
Nam, H. (2012) · NC Digital Online Collection of Knowledge and Scholarship (The University of North Carolina at Greensboro)
Santiago-Gómez, A. (2012) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Dead cells certainly do matter, particularly when they can speak from the grave
Sweet, M. J. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0810443
Self-citationEinfluss der Histon Deacetylase 6 auf den Glucocorticoid Rezeptor-vermittelten Glucosestoffwechsel
Winkler, R. (2012) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-4337
Regulation der inflammatorischen Antwort von Makrophagen durch die Histondeacetylase 5
Poralla, L. (2016) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-17923
Posttranslationale Kontrolle des zellulären Transkriptionsfaktors PBF/ZNF395
Fakultät, M.-N. (2012)
Dobreva, Z. G., & Stanilova, S. A. (2015) · doi:10.15547/tjs.2015.s.02.008
Cardiovascular Diseases and Personalized Epigenetics
Zawada, A. M., & Heine, G. H. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-420135-4.00018-8
The Transcription Factor ERG is a Gatekeeper of Endothelial Cell Homeostasis
Dryden, N. H. (2012) · Spiral (Imperial College London) · doi:10.25560/9798
Epigenetic regulation of macrophage function
Hoeksema, M. A. (2016) · UvA-DARE (University of Amsterdam)
An investigation of epigenetic effects in Atherosclerosis
Byrne, M. M. (2017) · Arrow@dit (Dublin Institute of Technology)
Role of Post-Translational Protein Modifications in Regulating HIV-1 and Mammalian Transcription
Ali, I. (2018) · eScholarship (California Digital Library)
Türel, S. (2018) · Pamukkale University Open Access Archive (Pamukkale University)
Михайловна, М. А., Евгеньевна, М. Н., & Pashenkov, M. V. (2022) · Immunologiya · doi:10.33029/0206-4952-2022-43-6-722-736
Grigorov, B., Platikanova, M., Dobreva, Z. G., Grigorova, A., & Stanilova, S. A. (2023) · Journal of IMAB - Annual Proceeding (Scientific Papers) · doi:10.5272/jimab.2023293.5108
Geens, M. M. (2012) · Lirias (KU Leuven)
Investigating the molecular mechanism of the anti-inflammatory effects of HDL in macrophages
Labzin, L. I. (2015) · bonndoc (University of Bonn)
Self-citationActivation microgliale : mécanismes et conséquences à long terme
Sigaut, S. (2017) · theses.fr (ABES) · doi:10.70675/cf41ca15z30a7z481fza678z8010a2cd328d
BindingDB Entry 50032567: Inhibitors selective for HDAC6 in enzymes and cells.
BindingDB (2011) · UC San Diego · doi:10.7270/q2fn16fw
Metadata
- Authors
- Halili, M. A., Andrews, M. R., Labzin, L. I., Schroder, K., Matthias, G., Cao, C., Lovelace, E., Reid, R. C., Le, G. T., Hume, D. A., Irvine, K. M., Matthias, P., Fairlie, D. P., & Sweet, M. J.
- Affiliations
- The University of Queensland (AU)
- University of Lausanne (CH)
- Friedrich Miescher Institute (CH)
- Roslin Institute (GB)
- Corresponding author
- Sweet, Matthew J
- ORCID
- Venue
- Journal of Leukocyte Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-03-03
- Volume
- 87
- Issue
- 6
- Pages
- 1103-1114
- ISSN
- 0741-5400 (ISSN-L)
- 1938-3673
- OpenAlex
- W2114231153
- Cited by
- 186
- References
- 51
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 6 · 2023: 9 · 2022: 8 · 2021: 11 · 2020: 16 · 2019: 5 · 2018: 13 · 2017: 8 · 2016: 26 · 2015: 15 · 2014: 13 · 2013: 17 · 2012: 16
- FWCI
- 6.64
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Leukocyte Biology (publishedVersion)
- PubMed (publishedVersion)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Funders
- ARC Special Research Centre for Functional and Applied Genomics
- Cancer Council Queensland (511205)
- Australian National Health and Medical Research Council (569735)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Keywords
- histone deacetylase inhibitors, macrophage inflammation, TLR4, lipopolysaccharide, atherosclerosis, trichostatin A, vorinostat, entinostat, HDAC6, HDAC1, cyclooxygenase-2, plasminogen activator inhibitor-1, IL-12, macrophages
- MeSH terms
- Histone Deacetylase 6, Vorinostat, Animals, Enzyme-Linked Immunosorbent Assay, Histone Deacetylases, Hydroxamic Acids, Inflammation, Lipopolysaccharides, Luciferases, Macrophages, Male, Mice, Inbred C57BL, RNA, Messenger, Blotting, Western, Plasminogen Activator Inhibitor 1, Mice, Knockout, Inflammation Mediators, Reverse Transcriptase Polymerase Chain Reaction, Chromatin Immunoprecipitation, Toll-Like Receptor 4, Mice, Cyclooxygenase 2, Interleukin-12 Subunit p40, Histone Deacetylase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.